SER Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Serina Therapeutics Inc (SER) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows weak technical indicators, insider selling, no positive news catalysts, and poor financial performance. Additionally, there are no proprietary trading signals or recent congress trading activity to support a buy decision.
The technical indicators are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 45.53, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 1.887 and resistance at 2.231.
NULL identified. There is no recent news or significant positive developments.
Insiders are selling heavily, with a 489.78% increase in selling activity over the last month. The stock has a 60% chance of declining further (-0.99% in the next day, -2.88% in the next week, -4.8% in the next month).
The company's financials for Q4 2025 show no revenue growth (0% YoY) and a net income of -$3,336,000, which is an improvement of 21.75% YoY but still negative. EPS improved slightly to -0.31 (up 3.33% YoY), and gross margin remains at 100%. Overall, the financials indicate poor performance with no signs of profitability.
No analyst rating or price target data available.
